Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million individual investors worldwide.
Stryker (NYSE:SYK) reported that an early-2026 cyber incident disrupted parts of its operations but did not derail overall demand.
The company highlighted record Mako robotics installations and broader use cases across orthopedic procedures.
International markets contributed more to growth, supported by new product approvals and expanding global adoption.
Stryker, trading around $312.2, has seen mixed share performance, with the stock down 10.3% year to date and down 16.5% over the past year, but up 29.0% over five years. In that context, the update on operational resilience after the cyber disruption and the emphasis on robotics and overseas contributions provides additional perspective on how the business is holding up. For investors tracking NYSE:SYK, this combination of short term pressure and longer term delivery is an important part of the story.
From here, the key questions are how quickly Stryker can further strengthen its systems after the cyber event and how far the Mako platform and international approvals can extend its footprint. For readers, the focus is less on the one off disruption and more on whether the company can continue converting its technology and global reach into consistent demand across procedures and regions.
Wall Street’s queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab’s valuation page.
NYSE:SYK Earnings & Revenue Growth as at Jun 2026
📰 Beyond the headline: 2 risks and 4 things going right for Stryker that every investor should see.
Quick Assessment
✅ Price vs Analyst Target: At $312.2, the stock trades about 19% below the $386.8 analyst consensus target.
✅ Simply Wall St Valuation: Shares are estimated to trade 17% below fair value, which points to a possible valuation gap.
✅ Recent Momentum: The stock is up 3.3% over the last 30 days, suggesting some positive short term interest after the cyber update.
There’s only one way to know the right time to buy, sell or hold Stryker. Head to Simply Wall St’s company report for the latest analysis of Stryker’s Fair Value.
Key Considerations
📊 The ability to keep robotics growth and international approvals on track after the cyber incident will shape how resilient you view the long term thesis.
📊 Keep an eye on Mako installation trends, international revenue mix, and any disclosures on cyber security spending or system upgrades.
⚠️ The flagged high debt level, alongside operational risk from future cyber events, is important when assessing downside if conditions turn.
Dig Deeper
For the full picture including more risks and rewards, check out the complete Stryker analysis. Alternatively, you can check out the community page for Stryker to see how other investors believe this latest news will impact the company’s narrative.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include SYK.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com